A competitive ligand binding assay for detection of neutralizing antibodies against an insulin analog
Authors:
- 14 October 2023
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 523, 113575
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Assessment and Reporting of the Clinical Immunogenicity of Therapeutic Proteins and Peptides—Harmonized Terminology and Tactical RecommendationsThe AAPS Journal, 2014
- Development and characterization of a non-cell-based assay to assess the presence of neutralizing antibodies to interferon-beta in clinical samplesJournal of Immunological Methods, 2013
- Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritisNature Reviews Rheumatology, 2013
- Development And Validation of Cell-Based Assays For The Detection of Neutralizing Antibodies to Drug Products: A Practical ApproachBioanalysis, 2012
- Comparison of competitive ligand-binding assay and bioassay formats for the measurement of neutralizing antibodies to protein therapeuticsJournal of Pharmaceutical and Biomedical Analysis, 2011
- An Affinity Capture Elution (ACE) assay for detection of anti-drug antibody to monoclonal antibody therapeutics in the presence of high levels of drugJournal of Immunological Methods, 2007
- Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2007
- Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeuticsJournal of Immunological Methods, 2007
- Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant ErythropoietinNew England Journal of Medicine, 2002
- PRISMS-4: Long-term efficacy of interferon-β-1a in relapsing MSNeurology, 2001